Bain Capital Life Sciences Investors, LLC sold $59M of HTFL
owner at Heartflow, Inc.. 2,000,000 shares at an average of $29.45, traded Apr 28, 2026, filed Apr 30, 2026.
Score components
- +12Role10% owner
- +25Trade size$58.9M at market
- +5Share of holdings soldSold 19% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +4.1%, 3m -13.2%, 6m -.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-198593, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 28, 2026 | SOpen-market sale Common Stockindirect: See footnotes | -254,110 | $30.51 | $7.8M | 10,194,048 | Apr 30, 2026 |
| Apr 29, 2026 | SOpen-market sale Common Stockindirect: See footnotes | -797,133 | $29.37 | $23M | 9,396,915 | Apr 30, 2026 |
| Apr 30, 2026 | SOpen-market sale Common Stockindirect: See footnotes | -892,533 | $29.18 | $26M | 8,504,382 | Apr 30, 2026 |
| Apr 30, 2026 | SOpen-market sale Common Stockindirect: See footnotes | -56,224 | $30.05 | $1.7M | 8,448,158 | Apr 30, 2026 |
Related signals
Other insiders at Heartflow, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | Heartflow, Inc. | Campbell Rogers Chief Medical Officer | $987k 19,682 shares | -20% | |
| 47Moderate | Heartflow, Inc. | Vikram Verghese Chief Financial Officer | $1.2M 24,345 shares | -14% | |
| 47Moderate | Heartflow, Inc. | Vikram Verghese Chief Financial Officer | $1.8M 34,975 shares | -16% | |
| 50Moderate | Heartflow, Inc. | John C.M. Farquhar Chief Executive Officer | $1.8M 38,900 shares | -11% | |
| 32Weak | Heartflow, Inc. | Vikram Verghese Chief Financial Officer | $332k 6,640 shares | -3% | |
| 40Moderate | Heartflow, Inc. | Vikram Verghese Chief Financial Officer | $1.7M 33,416 shares | -13% | |
| 45Moderate | Heartflow, Inc. | John C.M. Farquhar Chief Executive Officer | $1.4M 27,230 shares | -7% | |
| 38Weak | Heartflow, Inc. | John C.M. Farquhar Chief Executive Officer | $1.5M 32,676 shares | -8% | |
| 4Weak | Heartflow, Inc. | Campbell Rogers Chief Medical Officer | $380k 9,219 shares | -10% | |
| 33Weak | Heartflow, Inc. | John C.M. Farquhar Chief Executive Officer | $608k 15,560 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.